Albemarle completes expansion Pennsylvania manufacturing facility

Albemarle completes expansion of Pennsylvania manufacturing facility

10:33 AM, 11th December 2012
Albemarle completes expansion of Pennsylvania manufacturing facility

BATON ROUGE, US: Albemarle Corporation has completed an expansion at its Tyrone, Pennsylvania custom manufacturing facility. The expansion, which doubles the capacity for a proprietary chemical product manufactured for an Albemarle customer, began operation earlier in November and is now operating at full rates.

“Executing this multi-million dollar expansion in less than one year allowed our customer to capitalize on the growing demand for their product and the construction effort had no impact on fulfilling the production needs of our other customers,” said David DeCuir, Director, Fine Chemistry Services, Albemarle.

© WOC News 




Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

BASF appoints new President Director of Indonesia, CP Chan

JAKARTA, INDONESIA: Effective from 1 January 2013, Chan Choong Phooi (CP Chan) will be appointed as the new President Director of PT BASF Indonesia. H ...

Read more
LyondellBasell grants Spheripol technology license to Petronas

ROTTERDAM, THE NETHERLANDS: LyondellBasell announced Petroliam Nasional Berhad (Petronas) has selected the Spheripol process technology from LyondellB ...

Read more
Linde, Gazprom JV for helium production projects in Siberia

PARIS, FRANCE: Gazprom export LLC and Linde AG, have signed a Memorandum of Understanding (MOU) stipulating cooperation in implementing new helium pro ...

Read more
Evonik completes expansion of L-lysine capacity in Blair, US

ESSEN, GERMANY: Evonik Industries successfully completed its expansion of capacity for the feed amino acid L-lysine in North America in autumn 2012. P ...

Read more
Greenland witnesses increase in atmospheric acidity

WASHINGTON DC, US: In a new study, researchers have suggested that the decline in levels of the isotope nitrogen-15 is more directly related to increa ...

Read more
Asahi Kasei, Hisamitsu to sell HOB-294 in Japan

TOKYO, JAPAN: Hisamitsu Pharmaceutical and Asahi Kasei Pharma Corp have concluded a joint sales agreement in Japan for HOB-294 (oxybutynin hydrochlori ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X